GZ BYS PHARMACE -H-
GZ BYS PHARMACE -H- operates in Diversified Metals & Mining.
Market Cap & Net Worth: GZ BYS PHARMACE -H- (GU5)
GZ BYS PHARMACE -H- (BE:GU5) has a market capitalization of $19.53K (€19.03K) as of March 18, 2026. Listed on the BE stock exchange, this Germany-based company holds position #43811 globally and #7093 in its home market, demonstrating a -1.96% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying GZ BYS PHARMACE -H-'s stock price €2.00 by its total outstanding shares 9514 (9.51K).
GZ BYS PHARMACE -H- Market Cap History: 2015 to 2025
GZ BYS PHARMACE -H-'s market capitalization history from 2015 to 2025. Data shows growth from $2.24K to $19.53K (24.11% CAGR).
GZ BYS PHARMACE -H- Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how GZ BYS PHARMACE -H-'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.00x
GZ BYS PHARMACE -H-'s market cap is 0.00 times its annual revenue
0.01x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
0.00x
GZ BYS PHARMACE -H-'s market cap is 0.00 times its annual earnings
0.00x
Lower than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $2.47K | $20.04 Billion | $1.51 Billion | 0.00x | 0.00x |
| 2017 | $2.84K | $20.95 Billion | $2.06 Billion | 0.00x | 0.00x |
| 2018 | $4.08K | $42.23 Billion | $3.44 Billion | 0.00x | 0.00x |
| 2019 | $4.60K | $64.95 Billion | $3.19 Billion | 0.00x | 0.00x |
| 2020 | $3.94K | $61.67 Billion | $2.92 Billion | 0.00x | 0.00x |
| 2021 | $6.78K | $69.01 Billion | $3.72 Billion | 0.00x | 0.00x |
| 2022 | $10.92K | $70.79 Billion | $3.97 Billion | 0.00x | 0.00x |
| 2023 | $13.59K | $75.52 Billion | $4.06 Billion | 0.00x | 0.00x |
Competitor Companies of GU5 by Market Capitalization
Companies near GZ BYS PHARMACE -H- in the global market cap rankings as of March 18, 2026.
Key companies related to GZ BYS PHARMACE -H- by market ranking:
- BERKSHIRE HATH-A (BE:BRH): Ranked #2328 globally with a market cap of $6.43 Billion USD ( €6.27 Billion EUR).
- BERKSHIRE HATH-A - Dusseldorf Stock Exchang (DU:BRH): Ranked #2395 globally with a market cap of $6.17 Billion USD ( €6.02 Billion EUR).
- Itissalat Al-Maghrib (IAM) S.A (PINK:MAOTF): Ranked #3760 globally with a market cap of $3.25 Billion USD.
- NET ONE SYSTEMS (MU:NOX): Ranked #4660 globally with a market cap of $2.24 Billion USD ( €2.18 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #2328 | BERKSHIRE HATH-A | BE:BRH | $6.43 Billion | €634500.00 |
| #2395 | BERKSHIRE HATH-A - Dusseldorf Stock Exchang | DU:BRH | $6.17 Billion | €638000.00 |
| #3760 | Itissalat Al-Maghrib (IAM) S.A | PINK:MAOTF | $3.25 Billion | $14.80 |
| #4660 | NET ONE SYSTEMS | MU:NOX | $2.24 Billion | €1000000.00 |
GZ BYS PHARMACE -H- Historical Marketcap From 2015 to 2025
Between 2015 and today, GZ BYS PHARMACE -H-'s market cap moved from $2.24K to $ 19.53K, with a yearly change of 24.11%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | €19.53K | -11.50% |
| 2024 | €22.07K | +62.36% |
| 2023 | €13.59K | +24.44% |
| 2022 | €10.92K | +61.18% |
| 2021 | €6.78K | +72.08% |
| 2020 | €3.94K | -14.34% |
| 2019 | €4.60K | +12.58% |
| 2018 | €4.08K | +43.71% |
| 2017 | €2.84K | +15.02% |
| 2016 | €2.47K | +10.43% |
| 2015 | €2.24K | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of GZ BYS PHARMACE -H- was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $19.53K USD |
| MoneyControl | $19.53K USD |
| MarketWatch | $19.53K USD |
| marketcap.company | $19.53K USD |
| Reuters | $19.53K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.